Raghavendra Pudupakam

Lead Scientist I Oncology I Assay Development at ImpriMed, Inc. - Palo Alto, CA, US

Raghavendra Pudupakam's Contact Details
HQ
N/A
Location
Fremont,California,United States
Company
ImpriMed, Inc.
Raghavendra Pudupakam's Company Details
ImpriMed, Inc. logo, ImpriMed, Inc. contact details

ImpriMed, Inc.

Palo Alto, CA, US • 20 - 49 Employees
BioTech/Drugs

ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases. ImpriMed's key product, Chemo Response Prediction Service has been used by board-certified veterinary oncologists, helping over 2,000 dogs with lymphoma and leukemia. With ImpriMed's services, veterinarians make their treatment decisions quickly and with confidence. This innovative approach to cancer care has been published in a scientific journal and presented at major conferences and is supported by over 150 veterinary oncologists at 80+ specialty hospitals in the US.

N/A
Details about ImpriMed, Inc.
Frequently Asked Questions about Raghavendra Pudupakam
Raghavendra Pudupakam currently works for ImpriMed, Inc..
Raghavendra Pudupakam's role at ImpriMed, Inc. is Lead Scientist I Oncology I Assay Development.
Raghavendra Pudupakam's email address is ***@imprimedicine.com. To view Raghavendra Pudupakam's full email address, please signup to ConnectPlex.
Raghavendra Pudupakam works in the Research industry.
Raghavendra Pudupakam's colleagues at ImpriMed, Inc. are Enyang Han, Mary Ocnean, Amanda Polley, Elmer Fernandez, Sungwon Lim, John Callegari, Josephine Tsang and others.
Raghavendra Pudupakam's phone number is N/A
See more information about Raghavendra Pudupakam